ARCHIVES

Ungerleider To Leave NCI For Theradex Corp.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

ASCO Weighs In On Tobacco Debate

September 19, 1997

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost

March 8, 1996

Members of Congress say that won’t work.

September 30, 2005